MAG
GH icon

MRA Advisory Group’s Guardant Health GH Stock Holding History

MRA Advisory Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
12,026
+706
+6% +$76.8K 0.65% 32
2026
Q1 		$1.05M Buy
11,320
+724
+7% +$72.7K 0.43% 46
2025
Q4 		$1.08M Sell
10,596
-4,761
-31% -$426K 0.45% 37
2025
Q3 		$960K Sell
15,357
-996
-6% -$54.2K 0.42% 36
2025
Q2 		$851K Buy
16,353
+1,078
+7% +$48.1K 0.4% 33
2025
Q1 		$651K Buy
+15,275
New +$659K 0.35% 41

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MRA Advisory Group's GH Position: Q2 2026 in Review

MRA Advisory Group increased its Guardant Health (GH) stake by 6.2% in Q2 2026, buying an estimated $76.8K and bringing the position to 12,026 shares worth $1.8M. The position accounts for 0.65% of the portfolio, ranked #32.

MRA Advisory Group first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • MRA Advisory Group held 12,026 shares of Guardant Health worth $1.8M as of Q2 2026.
  • MRA Advisory Group bought 706 Guardant Health shares in Q2 2026, an estimated $76.8K.
  • Guardant Health made up 0.65% of MRA Advisory Group's portfolio in Q2 2026, its #32 holding.
  • MRA Advisory Group first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.